EcoDrugPlus

Ensembl ID : ENSCHYG00000014008
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCHYG00000013955
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSCHYG00000013703
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSCHYG00000017326
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSCHYG00000017914
Gene Symbol: -
Cross references: -
284 Possible Orthologues:

Ensembl ID : ENSCHYG00000020438
Gene Symbol: -
Cross references: -
105 Possible Orthologues:

Ensembl ID : ENSCHYG00000013700
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSCHYG00000013154
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSCHYG00000012610
Gene Symbol: -
Cross references: -
281 Possible Orthologues:

Ensembl ID : ENSCHYG00000012159
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSCHYG00000020437
Gene Symbol: -
Cross references: -
116 Possible Orthologues:

Ensembl ID : ENSCHYG00000024001
Gene Symbol: -
Cross references: -
405 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).